Funds holding ASPIRE BIOPHARMA HOLDINGS INC
ISIN US7389202067 · United States
- Fund holders
- 0
No tracked fund declares this company in its latest report.
Institutional managers
11 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| UBS Group AG | 191,499 | 197.2K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 76,955 | 79.3K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 43,384 | 44.7K $ | as of Mar 31, 2026 |
| Crewe Advisors LLC | 20,335 | 20.9K $ | as of Mar 31, 2026 |
| TORONTO DOMINION BANK | 5,000 | 5.2K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 2,174 | 2.2K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1,846 | 1.9K $ | as of Mar 31, 2026 |
| Avion Wealth | 1,352 | 1 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 2 | 2 $ | as of Mar 31, 2026 |
| Caitong International Asset Management Co., Ltd | 1 | 1 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 1 | 1 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding ASPIRE BIOPHARMA HOLDINGS INC". https://titelia.com/en/stocks/aspire-biopharma-holdings-inc-US7389202067